11-ketotestosterone has been researched along with Prostatic Neoplasms, Castration-Resistant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arlt, W; de Wit, R; Hamberg, P; Hofland, J; Lolkema, MP; Snaterse, G; Taylor, AE; van der Vlugt-Daane, M; van Dessel, LF; van Riet, J; Visser, JA | 1 |
| Africander, DJ; Perkins, MS; Pretorius, E; Quanson, J; Storbeck, KH; Vlok, M | 1 |
2 other study(ies) available for 11-ketotestosterone and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
11-Ketotestosterone is the predominant active androgen in prostate cancer patients after castration.
Topics: Aged; Aged, 80 and over; Androgen Receptor Antagonists; Androgens; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Glucocorticoids; Humans; Male; Middle Aged; Orchiectomy; Prostatectomy; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Receptors, Androgen; Testosterone; Transcriptome | 2021 |
11-Ketotestosterone and 11-Ketodihydrotestosterone in Castration Resistant Prostate Cancer: Potent Androgens Which Can No Longer Be Ignored.
Topics: Androgens; Animals; Biosynthetic Pathways; Cell Line, Tumor; Cell Proliferation; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Protein Binding; Receptors, Androgen; Response Elements; Testosterone | 2016 |